4//SEC Filing
Berge Terence M 4
Accession 0001127602-23-014082
CIK 0000816956other
Filed
May 1, 8:00 PM ET
Accepted
May 2, 4:12 PM ET
Size
24.2 KB
Accession
0001127602-23-014082
Insider Transaction Report
Form 4
CONMED CorpCNMD
Berge Terence M
VP Corp. Treasurer
Transactions
- Exercise/Conversion
Common Stock
2023-04-28$59.96/sh+5,400$323,784→ 9,204 total - Exercise/Conversion
Common Stock
2023-04-28$78.76/sh+5,400$425,304→ 14,604 total - Exercise/Conversion
Common Stock
2023-04-28$97.69/sh+5,100$498,219→ 19,704 total - Sale
Common Stock
2023-04-28$127.44/sh−2,800$356,832→ 16,904 total - Sale
Common Stock
2023-04-28$126.78/sh−5,400$684,612→ 11,504 total - Sale
Common Stock
2023-04-28$126.42/sh−5,400$682,668→ 6,104 total - Sale
Common Stock
2023-04-28$126.65/sh−5,100$645,915→ 1,004 total - Exercise/Conversion
Options To Purchase Common Stock
2023-04-28−2,800→ 0 totalExercise: $41.93Exp: 2031-03-01→ Common Stock (2,800 underlying) - Exercise/Conversion
Common Stock
2023-04-28$41.93/sh+2,800$117,404→ 3,804 total - Exercise/Conversion
Options To Purchase Common Stock
2023-04-28−5,400→ 0 totalExercise: $59.96Exp: 2028-03-01→ Common Stock (5,400 underlying) - Exercise/Conversion
Options To Purchase Common Stock
2023-04-28−5,400→ 2,700 totalExercise: $78.76Exp: 2029-03-01→ Common Stock (5,400 underlying) - Exercise/Conversion
Options To Purchase Common Stock
2023-04-28−5,100→ 5,100 totalExercise: $97.69Exp: 2030-03-02→ Common Stock (5,100 underlying)
Footnotes (5)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.25 to $127.80. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.60 to $127.23. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.54 to $126.99. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
- [F4]The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
- [F5]The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period
Documents
Issuer
CONMED Corp
CIK 0000816956
Entity typeother
Related Parties
1- filerCIK 0001635424
Filing Metadata
- Form type
- 4
- Filed
- May 1, 8:00 PM ET
- Accepted
- May 2, 4:12 PM ET
- Size
- 24.2 KB